Semmax Financial Advisors Inc. Sells 284 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Semmax Financial Advisors Inc. decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,787 shares of the healthcare conglomerate’s stock after selling 284 shares during the period. Semmax Financial Advisors Inc.’s holdings in UnitedHealth Group were worth $1,713,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Bellevue Group AG increased its position in UnitedHealth Group by 9.7% during the third quarter. Bellevue Group AG now owns 225,550 shares of the healthcare conglomerate’s stock valued at $131,875,000 after acquiring an additional 19,875 shares during the last quarter. Cobblestone Capital Advisors LLC NY lifted its stake in shares of UnitedHealth Group by 1.0% in the 3rd quarter. Cobblestone Capital Advisors LLC NY now owns 3,476 shares of the healthcare conglomerate’s stock worth $2,032,000 after purchasing an additional 33 shares during the period. Edgestream Partners L.P. bought a new position in UnitedHealth Group in the third quarter worth approximately $4,522,000. L.M. Kohn & Company increased its stake in shares of UnitedHealth Group by 1.6% in the 3rd quarter. L.M. Kohn & Company now owns 5,037 shares of the healthcare conglomerate’s stock worth $2,945,000 after purchasing an additional 81 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec increased its position in UnitedHealth Group by 129.7% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after buying an additional 581,324 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

Shares of NYSE:UNH opened at $610.20 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The business has a 50 day simple moving average of $585.43 and a two-hundred day simple moving average of $556.38. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market capitalization of $561.55 billion, a PE ratio of 39.75, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the firm earned $6.56 EPS. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.38%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Cantor Fitzgerald upped their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. TD Cowen upped their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Finally, Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $618.26.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.